News Analysis

» infectious disease, funding and CRISPR

Most Recent

image: Antiviral Immunotherapy Comes of Age

Antiviral Immunotherapy Comes of Age

By | December 4, 2017

T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

0 Comments

From analyses of surface protein evolution to tweets on social media, scientists are gathering all the data they can to accurately predict influenza dynamics.

4 Comments

image: GM Mosquitoes Closer to Release in U.S.

GM Mosquitoes Closer to Release in U.S.

By | October 13, 2017

The EPA is now in charge of regulating the use of Oxitec’s strain of Aedes aegypti, genetically engineered to reduce populations of the insects.

5 Comments

image: Was a Drop in CRISPR Firms’ Stock Warranted?

Was a Drop in CRISPR Firms’ Stock Warranted?

By | June 7, 2017

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

5 Comments

image: NSF Cuts PhD Training Grant

NSF Cuts PhD Training Grant

By | June 7, 2017

The federal science agency discontinued a funding stream for graduate students in environmental science because of administrative workload.

3 Comments

image: RNAi’s Future in Drug-Target Screening

RNAi’s Future in Drug-Target Screening

By | April 17, 2017

A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

0 Comments

image: With CRISPR, Modeling Disease in Mini Organs

With CRISPR, Modeling Disease in Mini Organs

By | May 6, 2016

Organoids grown from genetically edited stem cells are giving scientists a new tool to screen drugs and test treatments.

0 Comments

image: “Heroes of CRISPR” Disputed

“Heroes of CRISPR” Disputed

By | January 19, 2016

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

10 Comments

image: Credit for CRISPR: A Conversation with George Church

Credit for CRISPR: A Conversation with George Church

By | December 29, 2015

The media frenzy over the gene-editing technique highlights shortcomings in how journalists and award committees portray contributions to scientific discoveries.

9 Comments

image: Year in Review: CRISPR Blossoms

Year in Review: CRISPR Blossoms

By | December 16, 2015

As researchers work to improve the precision gene-editing technology, the community discusses the best way to use it.

0 Comments

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. The Rising Research Profile of 23andMe
    News Analysis The Rising Research Profile of 23andMe

    An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.

FreeShip